Leonard Leblanc Sells 500 Shares of AXT (NASDAQ:AXTI) Stock

AXT Inc (NASDAQ:AXTI) Director Leonard Leblanc sold 500 shares of AXT stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $89.59, for a total value of $44,795.00. Following the transaction, the director owned 119,129 shares of the company’s stock, valued at $10,672,767.11. This represents a 0.42% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

AXT Trading Down 0.4%

AXTI stock opened at $73.12 on Friday. AXT Inc has a 1-year low of $2.39 and a 1-year high of $143.16. The business’s 50 day simple moving average is $67.75 and its 200 day simple moving average is $67.64. The firm has a market capitalization of $4.79 billion, a PE ratio of 3,656.00 and a beta of 1.90.

AXT (NASDAQ:AXTI) last announced its quarterly earnings results on Thursday, July 30th. The semiconductor company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.12. AXT had a return on equity of 0.96% and a net margin of 3.23%.The business had revenue of $47.59 million during the quarter, compared to the consensus estimate of $34.08 million. AXT has set its Q3 2026 guidance at 0.300-0.320 EPS. As a group, sell-side analysts predict that AXT Inc will post 0.8 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

AXTI has been the topic of a number of research reports. Northland Securities set a $125.00 price target on shares of AXT in a research note on Wednesday, June 3rd. Zacks Research upgraded shares of AXT from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. UBS Group set a $90.00 price objective on AXT in a report on Friday, July 31st. B. Riley Financial decreased their target price on AXT from $73.00 to $52.00 and set a “neutral” rating on the stock in a research report on Tuesday, July 28th. Finally, Needham & Company LLC upgraded AXT from a “hold” rating to a “buy” rating and set a $90.00 target price on the stock in a research note on Friday, July 31st. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, AXT currently has a consensus rating of “Moderate Buy” and an average price target of $77.00.

Hedge Funds Weigh In On AXT

Hedge funds have recently bought and sold shares of the business. Teza Capital Management LLC acquired a new position in shares of AXT during the 2nd quarter worth approximately $352,000. Two Sigma Securities LLC acquired a new stake in shares of AXT in the second quarter valued at approximately $212,000. GTS Securities LLC acquired a new stake in shares of AXT in the second quarter valued at approximately $991,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of AXT by 11.7% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 85,925 shares of the semiconductor company’s stock valued at $6,193,000 after buying an additional 9,032 shares during the period. Finally, Wellington Management Group LLP bought a new stake in shares of AXT in the second quarter valued at approximately $25,911,000. 49.52% of the stock is owned by institutional investors.

AXT News Summary

Here are the key news stories impacting AXT this week:

• Positive Sentiment: AXT’s indium phosphide (InP) business is showing strong momentum, with record revenue, a backlog exceeding $100 million and planned capacity expansion. Demand from AI data centers and optical networking could provide a multiyear growth opportunity. AXT’s InP Demand Is Surging: Can It Become a Long-Term Growth Driver?
• Positive Sentiment: Reports that indium phosphide supply is tightening, alongside new AI-related deals, have supported the bullish view that AXT may benefit from rising demand for optical components used in high-speed data centers. Why AXT Is Up 11.6% After Indium Phosphide Supply Tightens Amid New AI Deals
• Neutral Sentiment: AXT’s latest quarterly results were materially better than expected, with earnings per share of $0.19 versus a $0.07 consensus estimate and revenue of $47.59 million versus $34.08 million. Management guided to third-quarter 2026 EPS of $0.30-$0.32, though the stock’s exceptionally high valuation leaves limited room for disappointment.
• Neutral Sentiment: Analyst opinion remains mixed but leans positive: AXT has a consensus “Moderate Buy” rating and an average price target of $77, while price targets range from $52 to $125. A Tradr ETF including AXT could improve visibility and investor access, but its direct fundamental impact is uncertain.
• Negative Sentiment: AXTI has faced a broader selloff in optics and AI-hardware shares as investors reassess the pace of AI spending and lock in gains after the sector’s major rally. This risk-off environment is currently outweighing the company’s favorable InP outlook. Optics Stocks Drop on Anthropic News
• Negative Sentiment: Director Leonard Leblanc has repeatedly reduced his stake, selling 4,000 shares on August 17 for about $384,280, 2,000 shares on August 7 and 500 shares in June. Although he still owns more than 113,000 shares, the pattern may weigh modestly on investor sentiment. Insider Selling: AXT Director Sells Shares

About AXT

AXT, Inc (NASDAQ: AXTI) is a global supplier of compound and single-element semiconductor substrates, offering a range of materials critical for high-performance electronic and optoelectronic devices. Founded in 1986 and headquartered in Fremont, California, AXT specializes in the development, manufacture and distribution of wafers composed of gallium arsenide (GaAs), indium phosphide (InP), gallium nitride (GaN) and other compound semiconductor materials. These substrates serve as the foundational platforms for devices used in data communications, wireless infrastructure, advanced computing, consumer electronics and photovoltaic applications.

AXT’s product portfolio encompasses a variety of wafer sizes, dopant concentrations and crystal orientations, tailored to meet the precise specifications of its customers.